Carlos González-Muñoza

8PUBLICATIONS
98CO-AUTHORS
Disease surveillancePredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Immunogenetics (incl. genetic immunology)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Dec 06, 2025
Comparative Study on the Management and Outcomes of Postoperative Crohn's Disease in Older Patients: Data From the ENEIDA Registry.

Míriam Mañosa, Margalida Calafat, Elena Ricart

|Jan 18, 2025
Inter-Rater Disagreements in Applying the Montreal Classification for Crohn's Disease: The Five-Nations Survey Study.

Offir Ukashi, Aurelien Amiot, David Laharie

|Jan 02, 2025
Ileal Predominance in Crohn's Disease Is Associated With Increased Intestinal Surgery and Biological Therapy Use, With Lower Treatment Persistence.

Antonio Giordano, Isabel Pérez-Martínez, Javier P Gisbert

|Jun 24, 2024
Influence of familial forms of inflammatory bowel disease on the use of immunosuppressants, biological agents, and surgery in the era of biological therapies. Results from the ENEIDA project.

Carlos González-Muñoza, Margalida Calafat, Javier P Gisbert

|Jun 19, 2024
The Usefulness of Intraepithelial Lymphocyte Immunophenotype Testing for the Diagnosis of Coeliac Disease in Clinical Practice.

Laura Gutiérrez-Rios, Margalida Calafat, Irene Pascual

|May 25, 2024
Trends in Targeted Therapy Usage in Inflammatory Bowel Disease: TRENDY Study of ENEIDA.

Celia Gómez-Labrador, Elena Ricart, Marisa Iborra

Pageof 2

Frequent Collaborators

6 joint publications

Eugeni Domènech

5 joint publications

Francisco Mesonero

4 joint publications

Manuel Barreiro-de Acosta

4 joint publications

Javier P Gisbert